Cargando…

Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is among the deadliest forms of cancer. While RNA-binding proteins (RBPs) have been shown to be key regulators of oncogenesis and tumor progression, their dysregulation in the context of HCC remains to be fully characterized. METHODS: Data from the Cancer G...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Min, Huang, Shan, Chen, Zefeng, Han, Zhiwei, Li, Kezhi, Chen, Chuang, Wu, Guobin, Zhao, Yinnong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684760/
https://www.ncbi.nlm.nih.gov/pubmed/33228611
http://dx.doi.org/10.1186/s12885-020-07625-3
_version_ 1783613063279149056
author Wang, Min
Huang, Shan
Chen, Zefeng
Han, Zhiwei
Li, Kezhi
Chen, Chuang
Wu, Guobin
Zhao, Yinnong
author_facet Wang, Min
Huang, Shan
Chen, Zefeng
Han, Zhiwei
Li, Kezhi
Chen, Chuang
Wu, Guobin
Zhao, Yinnong
author_sort Wang, Min
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is among the deadliest forms of cancer. While RNA-binding proteins (RBPs) have been shown to be key regulators of oncogenesis and tumor progression, their dysregulation in the context of HCC remains to be fully characterized. METHODS: Data from the Cancer Genome Atlas - liver HCC (TCGA-LIHC) database were downloaded and analyzed in order to identify RBPs that were differentially expressed in HCC tumors relative to healthy normal tissues. Functional enrichment analyses of these RBPs were then conducted using the GO and KEGG databases to understand their mechanistic roles. Central hub RBPs associated with HCC patient prognosis were then detected through Cox regression analyses, and were incorporated into a prognostic model. The prognostic value of this model was then assessed through the use of Kaplan-Meier curves, time-related ROC analyses, univariate and multivariate Cox regression analyses, and nomograms. Lastly, the relationship between individual hub RBPs and HCC patient overall survival (OS) was evaluated using Kaplan-Meier curves. Finally, find protein-coding genes (PCGs) related to hub RBPs were used to construct a hub RBP-PCG co-expression network. RESULTS: In total, we identified 81 RBPs that were differentially expressed in HCC tumors relative to healthy tissues (54 upregulated, 27 downregulated). Seven prognostically-relevant hub RBPs (SMG5, BOP1, LIN28B, RNF17, ANG, LARP1B, and NR0B1) were then used to generate a prognostic model, after which HCC patients were separated into high- and low-risk groups based upon resultant risk score values. In both the training and test datasets, we found that high-risk HCC patients exhibited decreased OS relative to low-risk patients, with time-dependent area under the ROC curve values of 0.801 and 0.676, respectively. This model thus exhibited good prognostic performance. We additionally generated a prognostic nomogram based upon these seven hub RBPs and found that four other genes were significantly correlated with OS. CONCLUSION: We herein identified a seven RBP signature that can reliably be used to predict HCC patient OS, underscoring the prognostic relevance of these genes.
format Online
Article
Text
id pubmed-7684760
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76847602020-11-24 Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma Wang, Min Huang, Shan Chen, Zefeng Han, Zhiwei Li, Kezhi Chen, Chuang Wu, Guobin Zhao, Yinnong BMC Cancer Research Article BACKGROUND: Hepatocellular carcinoma (HCC) is among the deadliest forms of cancer. While RNA-binding proteins (RBPs) have been shown to be key regulators of oncogenesis and tumor progression, their dysregulation in the context of HCC remains to be fully characterized. METHODS: Data from the Cancer Genome Atlas - liver HCC (TCGA-LIHC) database were downloaded and analyzed in order to identify RBPs that were differentially expressed in HCC tumors relative to healthy normal tissues. Functional enrichment analyses of these RBPs were then conducted using the GO and KEGG databases to understand their mechanistic roles. Central hub RBPs associated with HCC patient prognosis were then detected through Cox regression analyses, and were incorporated into a prognostic model. The prognostic value of this model was then assessed through the use of Kaplan-Meier curves, time-related ROC analyses, univariate and multivariate Cox regression analyses, and nomograms. Lastly, the relationship between individual hub RBPs and HCC patient overall survival (OS) was evaluated using Kaplan-Meier curves. Finally, find protein-coding genes (PCGs) related to hub RBPs were used to construct a hub RBP-PCG co-expression network. RESULTS: In total, we identified 81 RBPs that were differentially expressed in HCC tumors relative to healthy tissues (54 upregulated, 27 downregulated). Seven prognostically-relevant hub RBPs (SMG5, BOP1, LIN28B, RNF17, ANG, LARP1B, and NR0B1) were then used to generate a prognostic model, after which HCC patients were separated into high- and low-risk groups based upon resultant risk score values. In both the training and test datasets, we found that high-risk HCC patients exhibited decreased OS relative to low-risk patients, with time-dependent area under the ROC curve values of 0.801 and 0.676, respectively. This model thus exhibited good prognostic performance. We additionally generated a prognostic nomogram based upon these seven hub RBPs and found that four other genes were significantly correlated with OS. CONCLUSION: We herein identified a seven RBP signature that can reliably be used to predict HCC patient OS, underscoring the prognostic relevance of these genes. BioMed Central 2020-11-23 /pmc/articles/PMC7684760/ /pubmed/33228611 http://dx.doi.org/10.1186/s12885-020-07625-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Wang, Min
Huang, Shan
Chen, Zefeng
Han, Zhiwei
Li, Kezhi
Chen, Chuang
Wu, Guobin
Zhao, Yinnong
Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma
title Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma
title_full Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma
title_fullStr Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma
title_full_unstemmed Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma
title_short Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma
title_sort development and validation of an rna binding protein-associated prognostic model for hepatocellular carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684760/
https://www.ncbi.nlm.nih.gov/pubmed/33228611
http://dx.doi.org/10.1186/s12885-020-07625-3
work_keys_str_mv AT wangmin developmentandvalidationofanrnabindingproteinassociatedprognosticmodelforhepatocellularcarcinoma
AT huangshan developmentandvalidationofanrnabindingproteinassociatedprognosticmodelforhepatocellularcarcinoma
AT chenzefeng developmentandvalidationofanrnabindingproteinassociatedprognosticmodelforhepatocellularcarcinoma
AT hanzhiwei developmentandvalidationofanrnabindingproteinassociatedprognosticmodelforhepatocellularcarcinoma
AT likezhi developmentandvalidationofanrnabindingproteinassociatedprognosticmodelforhepatocellularcarcinoma
AT chenchuang developmentandvalidationofanrnabindingproteinassociatedprognosticmodelforhepatocellularcarcinoma
AT wuguobin developmentandvalidationofanrnabindingproteinassociatedprognosticmodelforhepatocellularcarcinoma
AT zhaoyinnong developmentandvalidationofanrnabindingproteinassociatedprognosticmodelforhepatocellularcarcinoma